Navier AI | $6,500,000 | (Dec 17, 2025)
AIR Platforms | $6,100,000 | (Dec 17, 2025)
Auxira Health | $7,800,000 | (Dec 17, 2025)
XL8.ai
United States
- SAN JOSE, CA
- 02/10/2023
- Series A
- $7,500,000
XL8 was founded in 2019 by technical executives from Google and Apple, both with an advanced degree in Computer Science from Columbia University. A Silicon Valley tech company at its core, XL8 takes AI-powered machine translation (MT), specially optimized for media content, to the next level. Its advanced technology allows significantly more efficient workflows by providing: in-line editing, automated media transcription with time coding, automated subtitling, synthesized voice dubbing, real-time meeting interpretation, and live subtitling. XL8’s uniquely specialized translation engines have been built from the ground up utilizing professionally trained, human-perfected subtitles curated from the media industry’s top content producers. XL8’s “secret sauce” offers media focused translation accuracy that is up to 40% higher than other generally available MT services. Since its inception, XL8 has surpassed translating 800,000 hours of content and more than 2.2 billion words, and currently supports more than 45 languages.
For more information visit xl8.ai or contact@xl8.ai
- Industry Software Development
- Website https://www.xl8.ai/
- LinkedIn https://www.linkedin.com/company/xl8-ai/about/
Mirelo AI | $41,000,000 | (Dec 17, 2025)
Lucis (YC X25) | $8,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)
Nanit | $50,000,000 | (Dec 17, 2025)
Culture Biosciences | Undisclosed Amount | (Dec 17, 2025)
YSE Beauty | $15,000,000 | (Dec 17, 2025)
Vital Lyfe | $24,000,000 | (Dec 17, 2025)
Dux Security | $9,000,000 | (Dec 17, 2025)